Infectious diseases remain a leading cause of childhood mortality worldwide, accounting for millions of deaths each year and disproportionately affecting children under five years of age. Despite advances in prevention and treatment, the global burden of infectious diseases remains immense and demands continued scientific investment.
Pediatric cancer patients are among those at greatest risk for life-threatening infections. Treatment-related complications account for more than half of all deaths, with infections being a major contributor. Even when not fatal, infections can delay or interrupt curative therapies and result in lasting health consequences.
Given their profound impact on pediatric outcomes, infections must remain a research and clinical priority. At St. Jude, the Departments of Host-Microbe Interactions and Infectious Diseases are dedicated to advancing our understanding of infection and microbial biology to develop innovative strategies for prevention, diagnosis and treatment of pathogenic threats.
Perspectives
Some of the most important ideas shaping the future come directly from the people leading the conversation. Perspectives elevates the voices of thought leaders who are tackling the challenges, opportunities and emerging trends that matter most to our work. Through their experiences and expertise, we gain fresh viewpoints, discover new ways of thinking and explore the issues driving progress in research, patient care and collaboration.
Impact in action
Emphasizing the ideas, discoveries and collaborations that are producing real-world results
Breakthroughs are made possible by the people, programs and infrastructure that bring ideas to life. Platforms powering discovery highlights dedicated efforts that provide the expertise, resources and connections needed to accelerate progress. From enabling cutting-edge research to fostering innovation across disciplines, these platforms serve as essential engines for discovery.
St. Jude has invested in several state-of-the-art collaborative centers that provide researchers with the unique services and technology needed to understand and treat catastrophic infectious diseases.
Advancing science and medicine depends on more than individual discoveries. It requires bringing people and ideas together. By convening the field, we create opportunities for new collaborations, connect researchers with complementary strengths, and help accelerate innovation that can ultimately improve human health.
